# Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer

> **NCT05742204** · — · ACTIVE_NOT_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 3700 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** Plasma protein biomarker analysis
- **OTHER:** Plasma protein biomarker analysis

## Key facts

- **NCT ID:** NCT05742204
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2032-10-31
- **Target enrollment:** 3700 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05742204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05742204, "Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05742204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*